Increased Rac1, Rac2, and, to a lesser extent, Rac3 activity were also observed in primary human CD34+ peripheral blood cells of CML patients and murine p210-BCR-ABL-expressing cells [61]. Here, RAC3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.